Linagliptin Lowers Albuminuria on Top of Recommended Standard Treatment in Patients With Type 2 Diabetes and Renal Dysfunction

OBJECTIVE: Preclinical data suggest that linagliptin, a dipeptidyl peptidase-4 inhibitor, may lower urinary albumin excretion. The ability of linagliptin to lower albuminuria on top of renin-angiotensin-aldosterone system (RAAS) inhibition in humans was analyzed by pooling data from four similarly d...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Groop, Per-Henrik, Cooper, Mark E., Perkovic, Vlado, Emser, Angela, Woerle, Hans-Juergen, von Eynatten, Maximilian
Format: Artigo
Jezik:Inglês
Izdano: American Diabetes Association 2013
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3816860/
https://ncbi.nlm.nih.gov/pubmed/24026560
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc13-0323
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki